Features
Advances in Pharmacotherapy of Schizophrenia
L. Michael Posey
Patients, practitioners, and payers are hoping that new antipsychotic
drugs now reaching the market will put a dent in the $23 billion
that schizophrenia treatment costs each year in the United States.
Liability and the Professional Imperative
Edward J. Krill
Traditionally, pharmacists have had no legal responsibility for
questioning the selection of a drug by a physician. However, as
pharmaceutical practice evolves and pharmacists become key resources
for comprehensive medication information, some courts are beginning
to take a different view of pharmacist liability.
Drug Distribution: Options for Enhancing Efficiency
L. Michael Posey
From tablet counters to robotic cassette fillers, automation is
expanding in pharmacies across the country. Consider the impact
the new technology is having on the long-term care world of punch
cards and complex regimens.
|

C O N T E N T S
November 1996/Volume 11, Number 11
|
|
|
About the artist: Eighty-seven-year-old Margaret Spann
has been painting "almost every day" all her life. A
Baltimore, Maryland, native, she vividly evokes the countryside
along Maryland's Eastern Shore with this month's cover painting,
"Autumn Hunt." Ms. Spann is a resident of The Fairfax,
a retirement community in Ft. Belvoir, Virginia.
|
Research & Reports
Clinical and Economic Outcomes Associated With A Histamine
H2 Receptor Antagonist Therapeutic Interchange Program
Thomas T. Ranz, Terrence E. O'Shea, Mark E. Lehman
This article examines clinical and economic outcomes of converting
nursing home residents' oral histamine H2 receptor
antagonist therapy from famotidine, cimetidine, or ranitidine
to nizatidine for treating peptic ulcer disease.
Clinical Reviews
Current Issues in the Diagnosis and Management of Depression
in the Elderly in the Long-term Care Setting
Laura A. Mandos
A review of current issues in the diagnosis and management of
depression in elderly people in the long-term care setting.
|